“Regulatory considerations for emergency use authorizations of medical products U/s 564 of the federal food drug and cosmetic act, usa” (2021) World Journal of Current Medical and Pharmaceutical Research, 3(5), pp. 116–119. doi:10.37022/wjcmpr.v3i5.192.